-
Mashup Score: 0Pitt study shows bariatric surgery is more effective than medical and lifestyle interventions for diabetes control and remission - 2 month(s) ago
Bariatric surgery is more effective than medical and lifestyle modifications for achieving long-term type 2 diabetes control and remission, according to new research from the University of Pittsburgh.
Source: www.eurekalert.orgCategories: General Medicine News, General NewsTweet
-
Mashup Score: 119 early warning signs and symptoms of type 2 diabetes - 2 month(s) ago
Being able to recognize the early signs and symptoms of type 2 diabetes is important. Learn more here.
Source: www.medicalnewstoday.comCategories: General Medicine News, General NewsTweet
-
Mashup Score: 10A diabetologists’ guide to subgroup meta-analyses – EASD e-Learning - 2 month(s) ago
Determining which treatment is suited best for specific patient groups can be a complex challenge. A recent study proposes a simple roadmap to guide clinicians through the interpretation of subgroup meta-analyses. Using data from recent cardiovascular outcome trials (CVOTs) with GLP-1 receptor agonists or SGLT2 inhibitors in patients with type 2 diabetes, the authors define four essential steps to consider when dealing with subgroup data. As the number of diabetes medications continues to grow, clinicians
Source: easd-elearning.euCategories: General Medicine News, EndocrinologyTweet
-
Mashup Score: 1Hemoglobin Levels Associated with Bone Density in Patients with T2D - 2 month(s) ago
A new analysis cites relatively high hemoglobin levels as a protective factor for bone quality in patients with type 2 diabetes.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 2Non-Insulin Diabetes Medications Safe for Infants in Early Pregnancy - 5 month(s) ago
Multinational data support the safety of drug classes like GLP-1 agonists during early relative to infant risk of major congenital malformations.
Source: www.hcplive.comCategories: General Medicine News, General HCPsTweet
-
Mashup Score: 0
Background Dipeptidyl peptidase-4 inhibitors (DPP-4i) have become firmly established in treatment algorithms and national guidelines for improving glycemic control in type 2 diabetes mellitus (T2DM).To report the findings from a multicenter, randomized, double-blind, placebo-controlled phase 3 clinical trial, which was designed to assess the efficacy and safety of a novel DPP-4 inhibitor fotagliptin in treatment-naive patients with T2DM. Methods Patients with T2DM were randomized to receive fotagliptin (n = 230), alogliptin (n = 113) or placebo (n = 115) at a 2:1:1 ratio for 24 weeks of double-blind treatment period, followed by an open-label treatment period, making up a total of 52 weeks. The primary efficacy endpoint was to determine the superiority of fotagliptin over placebo in the change of HbA1c from baseline to Week 24. All serious or significant adverse events were recorded. Results After 24 weeks, mean decreases in HbA1c from baseline were -0.70% for fotagliptin, -0.72% for a
Source: bmcmedicine.biomedcentral.comCategories: General Medicine Journals and Societies, Latest HeadlinesTweet
-
Mashup Score: 0
Home > Diabetes > Physical Activity in the Morning, Afternoon May Lower Type 2 Diabetes Risk A recent study published in Diabetologia showed that performing physical activity in the morning and afternoon is linked to a lower risk of developing type 2 diabetes. Physical activity is a known preventive factor of type 2 diabetes, but less is u nderstood about the ideal timing and consistency. Previous research has shown that performing physical activity in the midday-to-afternoon range, but not in the
Source: www.docwirenews.comCategories: Latest Headlines, Partners & KOLsTweet
-
Mashup Score: 0Association Between Onset of Type 2 Diabetes and Risk of Atrial Fibrillation in New Zealanders With Impaired Glucose Tolerance Over 25 Years - 7 month(s) ago
Background The association between the onset of type 2 diabetes (T2D) and atrial fibrillation (AF) risk in individuals with impaired glucose tolerance (IGT) remains unclear. This study aimed to inv…
Source: www.ahajournals.orgCategories: Cardiology News and Journals, Latest HeadlinesTweet
-
Mashup Score: 0The Use of Diabetes Technology to Educate and Support Persons With Newly Diagnosed Type 2 Diabetes - 7 month(s) ago
In this podcast, Eyitayo Owolabi, PhD, RN, discusses how diabetes technology is being used to support and educate patients with newly diagnosed type 2 diabetes, including addressing health care access barriers and promoting medication use, blood glucose monitoring, risk-reduction, problem-solving, healthy coping, engaging in healthy dietary practices, and physical activity. Dr Owolabi also presented on this topic at ADCES 2023 during a poster presentation titled Technology-Based Diabetes Education and Support for Persons Newly Diagnosed with T2D: A Scoping Review.
Source: www.consultant360.comCategories: General Medicine News, Latest HeadlinesTweet
-
Mashup Score: 0Applying New NAFLD Recommendations in Type 2 Diabetes, with Sarah Wheeler, PharmD, and John Bucheit, PharmD - 7 month(s) ago
Sarah Wheeler, PharmD, and John Bucheit, PharmD, provide perspective on contemporary trends in screening and management of nonalcoholic fatty liver disease in people with type 2 diabetes.
Source: www.hcplive.comCategories: General Medicine News, Latest HeadlinesTweet
A new @PittTweet study reveals that bariatric surgery may be more effective than medical and lifestyle modifications for achieving long-term #Type2Diabetes control and remission. @JAMA_current https://t.co/EnGcAL84RS